삼성서울병원

Ko En

Ahn, Yong Chan M.D

TITLE
Professor
Department of Radiation Oncology
Samsung Medical Center
Sungkyunkwan University School of Medicine
Treament Schedule 11 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
AM
PM
Treament Schedule 12 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
TUE
31
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   1992. 08 ~ 1993. 06: Research Fellow, Roswell Park Cancer Institute, USA
1993. 07 ~ 1994. 04: Clinical Fellow, British Columbia Cancer Agency, Canada
Residency   1989. 05 ~ 1992. 02: Seoul National University Hospital
Internship   1984. 03 ~ 1985. 02: Seoul National University Hospital

Other Education

2003. 08 ~ 2003. 10: Visiting Professor, Hokkaido University Medical School

Clinical & Research Interests

Head/Neck Oncology
Thoracic Oncology (Lung cancer, Esophageal cancer, Mediastinal tumor)
Stomach Cancer
Lymphoma
Sarcoma

Participation in Academic Societies
and Research

Domestic:
2001. 01 ~ Director, The Korean Lung Cancer Study Group
2004. 07 ~ Director, Korean Cancer Association
2004. 10 ~ 2007. 09: Director of General Affairs and Treasury, Korean Society for Therapeutic Radiology and Oncology
2007. 10 ~ Director of Board Qualifying Examination, Korean Society for Therapeutic Radiology and Oncology
2008. 10 ~ Vice-Editor-in-Chief, Korean Cancer Association
2008. 11 ~ Director of Public Relation, Korean Society for Head & Neck Oncology

International Membership:
American Society for Therapeutic Radiology and Oncology (ASTRO)
European Society for Therapeutic Radiology and Oncology (ESTRO)

Selected Publications

  • RADIOTHERAPY AND ONCOLOGY, FEB 2017, 122(2):217-223, DOI: 10.1016/j.radonc.2016.09.015 A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer Lee JY1, Sun JM, Oh D, Lim SH, Chi S, Lee SH, Jung SH, Ahn MJ, Ahn YC, Park K
    View PubMed
  • Pathol Res Pract. 2017 Feb;213(2):106-112. doi: 10.1016/j.prp.2016.11.012. Epub 2016 Nov 15. Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature Kwon AY11, Han J2, Chu J1, Choi YS3, Jeong BH4, Ahn MJ5, Ahn YC6.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):3542-3552. doi: 10.18632/oncotarget.12200. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery Cho WK11, Oh D1, Ahn YC1, Shim YM2, Zo JI2, Sun JM3, Ahn MJ3, Park K3.
    View PubMed
  • J Radiat Res. 2017 Jan;58(1):155-163. doi: 10.1093/jrr/rrw089. Epub 2016 Sep 26. Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study Yu JI11, Park HC2,3, Ahn YC1,3, Gao XS4, Wang JJ5, Zeng ZC6, Ito Y7, Ohno T8, Nishimura Y9.
    View PubMed
  • Ann Surg Oncol. 2016 Dec;23(13):4368-4375. Epub 2016 Jun 24. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy Cho JK11, Lim BW1, Kim EH2, Ko YH3, Oh D4, Noh JM4, Ahn YC4, Baek KH5, Jeong HS6.
    View PubMed